1-6 of 6
Emad A. Rakha
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer

Anastasia Constantinidou, Yiola Marcou, Michael S. Toss, Timothy Simmons, Ryan Bernhisel, Elisha Hughes, Braden Probst, Stephanie Meek, Eleni Kakouri, Georgios Georgiou, Ioanna Zouvani, Gabriella Savvidou, Vanessa Kuhl, Jennifer Doedt, Susanne Wagner, Alexander Gutin, Thomas P. Slavin, Jerry S. Lanchbury, Ralf Kronenwett, Ian O. Ellis, Emad A. Rakha
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (20): 4435–4443.
https://doi.org/10.1158/1078-0432.CCR-22-0619
Published: 14 October 2022
View article titled, Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer
Open the PDF for Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Nigel Bundred, Nuria Porta, Adrian Murray Brunt, Angela Cramer, Andrew Hanby, Abeer M. Shaaban, Emad A. Rakha, Anne Armstrong, Ramsey I. Cutress, David Dodwell, Marie A. Emson, Abigail Evans, Sue M. Hartup, Kieran Horgan, Sarah E. Miller, Stuart A. McIntosh, James P. Morden, Jay Naik, Sankaran Narayanan, Jane Ooi, Anthony I. Skene, David A. Cameron, Judith M. Bliss
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1323–1334.
https://doi.org/10.1158/1078-0432.CCR-21-3177
Published: 01 April 2022
View article titled, Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Open the PDF for Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results in another window
Includes: Supplementary data
Journal Articles

A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ

Karuna Mittal, Michael S. Toss, Guanhao Wei, Jaspreet Kaur, Da Hoon Choi, Brian D. Melton, Remus M. Osan, Islam M. Miligy, Andrew R. Green, Emiel A.M. Janssen, Håvard Søiland, Keerthi Gogineni, Upender Manne, Padmashree Rida, Emad A. Rakha, Ritu Aneja
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (12): 2898–2907.
https://doi.org/10.1158/1078-0432.CCR-19-1272
Published: 15 June 2020
View article titled, A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma <em>In Situ</em>
Open the PDF for A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma <em>In Situ</em> in another window
Includes: Supplementary data
Journal Articles

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer

Chun Gong, Ellen P.S. Man, Ho Tsoi, Terence K.W. Lee, Paul Lee, Sai-Ting Ma, Lai-San Wong, Mai-Yee Luk, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Eric W.-F. Lam, Kwok-Leung Cheung, Ui-Soon Khoo
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3681–3691.
https://doi.org/10.1158/1078-0432.CCR-17-2259
Published: 31 July 2018
View article titled, BQ323636.1, a Novel Splice Variant to <em>NCOR</em>2, as a Predictor for Tamoxifen-Resistant Breast Cancer
Open the PDF for BQ323636.1, a Novel Splice Variant to <em>NCOR</em>2, as a Predictor for Tamoxifen-Resistant Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer

Hetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, Manikandan Periyasamy, Alison Harrod, Carolina Gemma, Jennifer H. Steel, Naina Patel, Claudia Busonero, Dena Jerjees, Judit Remenyi, Sally Smith, Jennifer J. Gomm, Luca Magnani, Balázs Győrffy, Louise J. Jones, Frances Fuller-Pace, Sami Shousha, Laki Buluwela, Emad A. Rakha, Ian O. Ellis, R. Charles Coombes, Simak Ali
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (23): 5929–5938.
https://doi.org/10.1158/1078-0432.CCR-15-1104
Published: 30 November 2016
View article titled, Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer
Open the PDF for Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

Emad A. Rakha, Somaia E. Elsheikh, Muhammed A. Aleskandarany, Hany O. Habashi, Andrew R. Green, Desmond G. Powe, Maysa E. El-Sayed, Ahmed Benhasouna, Jean-Sébastien Brunet, Lars A. Akslen, Andy J. Evans, Roger Blamey, Jorge S. Reis-Filho, William D. Foulkes, Ian O. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2302–2310.
https://doi.org/10.1158/1078-0432.CCR-08-2132
Published: 01 April 2009
View article titled, Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Open the PDF for Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes in another window